Literature DB >> 7731012

Farnesyl derivatives of rigid carboxylic acids-inhibitors of ras-dependent cell growth.

D Marciano1, G Ben-Baruch, M Marom, Y Egozi, R Haklai, Y Kloog.   

Abstract

Inhibitors of the enzyme that methylates ras proteins, the prenylated protein methyltransferase (PPMTase), are described. They are farnesyl derivatives of rigid carboxylic acids that recognize the farnesylcysteine recognition domain of the enzyme but do not serve as substrates. They also inhibit ras-dependent cell growth by a mechanism that is probably unrelated to inhibition of ras methylation, even though their potencies as PPMTase inhibitors and cell-growth inhibitors correlate well. The most potent inhibitor is S-trans,trans-farnesylthiosalicylic acid (FTS) (2). FTS (2) selectively inhibits the growth of human Ha-ras-transformed Rat1 cells in vitro (EC50 = 7.5 microM).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7731012     DOI: 10.1021/jm00008a004

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  30 in total

1.  S-Farnesyl-Thiopropionic Acid (FTPA) Triazoles as Potent Inhibitors of Isoprenylcysteine Carboxyl Methyltransferase.

Authors:  Joel A Bergman; Kalub Hahne; Jiao Song; Christine A Hrycyna; Richard A Gibbs
Journal:  ACS Med Chem Lett       Date:  2011-11-28       Impact factor: 4.345

Review 2.  How to Target Activated Ras Proteins: Direct Inhibition vs. Induced Mislocalization.

Authors:  Ethan J Brock; Kyungmin Ji; John J Reiners; Raymond R Mattingly
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

Review 3.  Inhibition of Ras for cancer treatment: the search continues.

Authors:  Antonio T Baines; Dapeng Xu; Channing J Der
Journal:  Future Med Chem       Date:  2011-10       Impact factor: 3.808

4.  The isoprenoid substrate specificity of isoprenylcysteine carboxylmethyltransferase: development of novel inhibitors.

Authors:  Jessica L Anderson; Brian S Henriksen; Richard A Gibbs; Christine A Hrycyna
Journal:  J Biol Chem       Date:  2005-06-09       Impact factor: 5.157

5.  Novel Ras antagonist blocks human melanoma growth.

Authors:  B Jansen; H Schlagbauer-Wadl; H Kahr; E Heere-Ress; B X Mayer; H Eichler; H Pehamberger; M Gana-Weisz; E Ben-David; Y Kloog; K Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

6.  Amide-substituted farnesylcysteine analogs as inhibitors of human isoprenylcysteine carboxyl methyltransferase.

Authors:  James L Donelson; Heather B Hodges; Daniel D Macdougall; Brian S Henriksen; Christine A Hrycyna; Richard A Gibbs
Journal:  Bioorg Med Chem Lett       Date:  2006-06-13       Impact factor: 2.823

7.  Treatment of MRL/lpr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS).

Authors:  A Katzav; Y Kloog; A D Korczyn; H Niv; D M Karussis; N Wang; R Rabinowitz; M Blank; Y Shoenfeld; J Chapman
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

8.  Repositioning Salirasib as a new antimalarial agent.

Authors:  Exequiel O J Porta; Ignasi Bofill Verdaguer; Consuelo Perez; Claudia Banchio; Mauro Ferreira de Azevedo; Alejandro M Katzin; Guillermo R Labadie
Journal:  Medchemcomm       Date:  2019-06-21       Impact factor: 3.597

9.  Prevention of induced colitis in mice by the ras antagonist farnesylthiosalicylic acid.

Authors:  Tal Oron; Galit Elad-Sfadia; Roni Haklai; Elizabeta Aizman; Eli Brazowski; Yoel Kloog; Shimon Reif
Journal:  Dig Dis Sci       Date:  2011-09-08       Impact factor: 3.199

10.  PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel.

Authors:  Xiaolan Zhang; Jianqin Lu; Yixian Huang; Wenchen Zhao; Yichao Chen; Jiang Li; Xiang Gao; Raman Venkataramanan; Ming Sun; Donna Beer Stolz; Lin Zhang; Song Li
Journal:  Bioconjug Chem       Date:  2013-03-01       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.